Now showing items 1-2 of 2

    • Participation in Clinical Research Could Modify Background Risk for Trial Outcome Measures 

      Ndibazza, Juliet; Abaasa, Andrew M.; Asiki, Gershim; Levin, Jonathan; Bahemuka, Ubaldo; Ruzagira, Eugene; Kibengo, Freddie M.; Mulondo, Jerry; Price, Matthew A.; Fast, Pat; Kamali, Anatoli (2014)
      Data on HIV incidence and retention are needed to inform study design of efficacy trials. However, the selection criteria and interventions during an actual clinical trial could reduce HIV incidence and thus affect the ...
    • Risk of Being Seropositive for Multiple Human Papillomavirus Types Among Finnish and Ugandan Women 

      Namujju, Bazanya Proscovia; Surcel, Heljä-Marja; Kirnbauer, Reinhard; Kaasila, Marjo; Banura, Cecily; Byaruhanga, Romano; Muwanga, Moses; Mbidde, Katongole Edward; Koskela, Pentti; Lehtinen, Matti (Informa Healthcare, Taylor & Francis, 2010-02-24)
      Although infections with multiple human papillomavirus (HPV) types have been reported widely, more information is needed on the occurrence of the different types. We determined the distribution of seroprevalences to multiple ...